These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29900135)
1. Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis. Zheng S; Zheng Y; Jin L; Zhou Z; Li Z Iran J Public Health; 2018 Apr; 47(4):510-518. PubMed ID: 29900135 [TBL] [Abstract][Full Text] [Related]
2. Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis. Yu L; Kang L; Ren XZ; Diao ZL; Liu WH Kidney Blood Press Res; 2018; 43(4):1174-1182. PubMed ID: 30064142 [TBL] [Abstract][Full Text] [Related]
3. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients. Xiong L; Chen QQ; Cheng Y; Lan YS; Yang JB; Wen XQ; Xie X; Kang T; Wu WH; Ou S BMC Nephrol; 2023 Aug; 24(1):238. PubMed ID: 37582785 [TBL] [Abstract][Full Text] [Related]
4. Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis. Yu LX; Liu QF; Feng JH; Li SS; Gu XX; Xiong Y; Qiang-Sun ; Ye JM Dis Markers; 2020; 2020():4923970. PubMed ID: 33299496 [TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-29b and Sclerostin Levels Correlate with Coronary Artery Calcification and Cardiovascular Events in Maintenance Hemodialysis Patients. He J; Pan M; Xu M; Chen R Cardiol Res Pract; 2021; 2021():9208634. PubMed ID: 34976409 [TBL] [Abstract][Full Text] [Related]
6. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients. Buiten MS; de Bie MK; Bouma-de Krijger A; van Dam B; Dekker FW; Jukema JW; Rabelink TJ; Rotmans JI BMC Nephrol; 2014 Dec; 15():197. PubMed ID: 25495997 [TBL] [Abstract][Full Text] [Related]
7. Association between serum cartilage oligomeric matrix protein and coronary artery calcification in maintenance hemodialysis patients. Ha L; Shi JB; Yu HY; Yang K; Wang HN; Wang FF; Han JL J Geriatr Cardiol; 2020 Feb; 17(2):67-73. PubMed ID: 32165879 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration. Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904 [TBL] [Abstract][Full Text] [Related]
9. Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients. Wang M; Li H; You L; Yu X; Zhang M; Zhu R; Hao C; Zhang Z; Chen J PLoS One; 2014; 9(4):e93360. PubMed ID: 24747427 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients. Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors for coronary artery calcification in patients with end-stage renal disease]. Cui L; Xu J; Bai Y; Zhang J Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(38):3133-7. PubMed ID: 26814105 [TBL] [Abstract][Full Text] [Related]
12. Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis. Zhang AH; Guo WK; Yu L; Liu WH Kidney Blood Press Res; 2019; 44(3):396-404. PubMed ID: 31079116 [TBL] [Abstract][Full Text] [Related]
13. A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients. Cai H; Zhu X; Lu J; Zhu M; Liu S; Zhan Y; Ni Z; Gu L; Zhang W; Mou S Front Med (Lausanne); 2021; 8():672000. PubMed ID: 34079811 [No Abstract] [Full Text] [Related]
14. The predictive value of coronary artery calcification score combined with bone mineral density for the 2-year risk of cardiovascular events in maintenance hemodialysis patients. Huang J; Bao L; Pan Y; Lu Q; Huang Y; Ding Q; Shen F; Huang Q; Ruan X Int Urol Nephrol; 2022 Apr; 54(4):883-893. PubMed ID: 34279820 [TBL] [Abstract][Full Text] [Related]
15. Association Between Angiotensin-Converting Enzyme 2 and Coronary Artery Calcification in Patients on Maintenance Hemodialysis Therapy. Zhang Q; Sun L; Jin L Ther Apher Dial; 2015 Oct; 19(5):466-70. PubMed ID: 26112236 [TBL] [Abstract][Full Text] [Related]